Does PEMBROLIZUMAB Cause Immune-mediated myocarditis? 599 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 599 reports of Immune-mediated myocarditis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.7% of all adverse event reports for PEMBROLIZUMAB.
599
Reports of Immune-mediated myocarditis with PEMBROLIZUMAB
0.7%
of all PEMBROLIZUMAB reports
176
Deaths
400
Hospitalizations
How Dangerous Is Immune-mediated myocarditis From PEMBROLIZUMAB?
Of the 599 reports, 176 (29.4%) resulted in death, 400 (66.8%) required hospitalization, and 128 (21.4%) were considered life-threatening.
Is Immune-mediated myocarditis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 599 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Immune-mediated myocarditis?
NIVOLUMAB (444)
IPILIMUMAB (248)
CARBOPLATIN (93)
DURVALUMAB (74)
LENVATINIB (66)
DOXORUBICIN (59)
PACLITAXEL (58)
PEMETREXED (43)
ATEZOLIZUMAB (37)
BEVACIZUMAB (32)
Which PEMBROLIZUMAB Alternatives Have Lower Immune-mediated myocarditis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G